These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8337123)

  • 21. Mechanism-based therapy for leukemia: a lesson from ATRA therapy.
    Naoe T
    Nagoya J Med Sci; 2001 Nov; 64(3-4):103-8. PubMed ID: 11820331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.
    Tallman MS; Rowe JM
    Blood Rev; 1994 Jun; 8(2):70-8. PubMed ID: 7950477
    [No Abstract]   [Full Text] [Related]  

  • 23. [The pathogenesis and treatment of the hemostatic disorder in acute promyelocytic leukemia].
    Velasco F; López-Pedrera R; Páramo JA
    Med Clin (Barc); 1996 Jun; 107(2):59-61. PubMed ID: 8753897
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
    Yang J; Han Z; Pei M; Xiao N
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid].
    Miyoshi T; Otsuki T; Omine K; Kirito K; Nagai T; Izumi T; Komatsu N; Madoiwa S; Mimuro J; Sakata Y; Ozawa K
    Rinsho Ketsueki; 2002 Oct; 43(10):954-9. PubMed ID: 12462033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recently recognized entity associated with the treatment of acute promyelocytic leukemia: the retinoic acid syndrome.
    Marinakis T; Papadimitriou CA; Koufos C; Fertakis A
    Haematologica; 1993; 78(3):192-4. PubMed ID: 8375752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
    Takada S; Matumoto K; Sakura T; Shiozaki H; Miyawaki S
    Int J Hematol; 1999 Jul; 70(1):26-9. PubMed ID: 10446491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid receptors, hematopoiesis and leukemogenesis.
    Collins SJ
    Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T
    Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac tamponade and cardiogenic shock as a manifestation of all-trans retinoic acid syndrome: an association not previously reported.
    Larrea L; de la Rubia J; Jiménez C; Martín G; Sanz MA
    Haematologica; 1997; 82(4):463-4. PubMed ID: 9299864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of all-trans retinoic acid-induced myositis in the treatment of acute promyelocytic leukaemia.
    Chan KH; Yuen SL; Joshua D
    Clin Lab Haematol; 2005 Dec; 27(6):399-401. PubMed ID: 16307543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia.
    Jagdeo J; Campbell R; Long T; Muglia J; Telang G; Robinson-Bostom L
    J Am Acad Dermatol; 2007 Apr; 56(4):690-3. PubMed ID: 17367621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of cytokines on hyperleukocytosis associated with acute promyelocytic leukemia induced by all-trans retinoic acid therapy].
    Hino K; Nakamaki T
    Rinsho Ketsueki; 1996 Sep; 37(9):770-6. PubMed ID: 8914460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day.
    Lemez P
    Eur J Haematol; 1995 Oct; 55(4):275-6. PubMed ID: 7589349
    [No Abstract]   [Full Text] [Related]  

  • 39. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 40. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
    N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.